The Malta Independent 16 November 2026, Monday
View E-Paper

Prescribing And government expense

Malta Independent Wednesday, 29 September 2010, 00:00 Last update: about 13 years ago

I was honoured again this year to be invited by the Italian College of Family Doctors who held once again, in Caserta, a conference on medico-legal issues. I was asked to invite two colleagues from the UK and Holland. We heatedly discussed the gatekeeper role in the prescription of medicines in the respective countries. Now with the new proposal on the primary health care reform in the hands of cabinet, and what with some debates in the past on whether doctors receive compensation for prescribing, this issue should be addressed again. I wish to look at the situation in the UK and that in Italy, two contrasting states, where doctors are very upset about the moral position they are put in, especially because they are policed by the guardia di finanza, income tax police, as it were.

The situation in Italy is not very healthy for GPs to be in. The government will pay for any drug that the GP prescribes to the patient. The problem is that the GP is allowed a choice between the branded drug and the generic. The issue is that GPs can be favoured by companies to prescribe one drug and not the other, and thus they are policed by the guardia. These in turn, have a right not only to arrest the GP only on suspicion – and it is up to him to fork out the money to defend himself, and to deal with the worry until cases are heard – but also GPs must forfeit the right to confidentiality of patient files. The Dutch colleague, much to the pleasure of the audience, asked how can it be that the guardia, who are not medically qualified, are asked to look into patient files and try to interpret why the GP prescribed one drug and not the other.

The doctors argued that although they are paid by the government, there is ample space for patients to shop around as they can easily unregister themselves from one doctor and register with another. This leaves the doctor, who is being paid on a per capita basis, prone to competition with colleagues. They ask, if the patient specifically requests for a branded drug, how can they go against the patient’s wishes simply to save money to the government? Moreover why should they be held responsible when often it is a specialist in an area who prescribes one drug over another, making it of course impossible for the GP to change? Yet they are the ones being policed.

A representative of the pubic health said that GPs should have the freedom to choose which drug to prescribe but also should take on the responsibility to save money from the government coffers, because at the end of the day all drugs are paid from tax-payers money. This all sounds incredibly saintly but reality has it differently. In fact the moral responsibility for choosing the drug which costs less is fraught with moral issues as well. If I prescribe a branded drug to one patient, why should I not prescribe it to another? Unless there are specific criteria for choosing a brand name over a generic name, and these criteria have to be objectively done by the department of health, a choice left in the hands of the GP is simply passing the buck, or the hot potato, as it were, to someone else. The GP can be accused of double standards. And if I show preference to one patient over another, I slowly but surely will lose patients – and rightly so. Yet their government persists in not making this important call.

Or once at least I felt that something was good with our system. I was asked about our system and simply said that patients have a right to choose whether to go to a health centre or a private family doctor, and in both cases have a right to choose whether to buy a drug or get one free. Free drugs depend on whether you have a chronic disease or fall into a bracket were you can benefit from any kind of drug. But in both cases it is the government who makes the bargaining. If you opt for the free drug, you have to take the one which the government bought. There are choices, sometimes, to be made by consultants on whether one should have one brand over another, but these have specific criteria. Theoretically (were it not that people can go to politicians and pass through the window) it works quite well. We need to be careful to learn from our neighbour European states.

In the UK, another system is used. Doctors living in urban areas do not dispense drugs, as is usual; but doctors living in rural areas can have a pharmacy of their own and indeed dispense drugs. If there is no pharmacy within one mile of the practice, then doctors can dispense drugs. This may sound unethical to the uninitiated; and indeed can be abused. It certainly is another source of income for these GPs – and there are quite a few – but it benefits both patient and government. Does this mean that ethics is sold for convenience? Not exactly. As the GP present explained, doctors put pressure on themselves not to abuse the system – if they did, it would not benefit the government and therefore not the patient and they lose that privilege. Given that there is nothing wrong with earning money for a service, one can justify the ethical issues involved. Now one notes that even here the GP has a choice between a generic drug and a brand drug but there are two specific things which do not create the problems faced by their Italian counterparts.

First the GP is not policed. All he has to answer to is the profession and peer review can put him back on track if he is seen to be overdoing it. Secondly the GP is allowed to bargain with drug distributors for a better price. This makes it sometimes worth prescribing what would otherwise be a more expensive drug. Now the government is quite aware of this legal bargaining and indeed takes it into consideration when offering the GPs the annual budget – as in the UK GPs manage a fund and therefore act as gatekeepers. So if in the previous year the government gave a subsidy of 5GBP for a particular drug; the following year, knowing that the GP obtained a 2GBP discount on that drug, the government can decide to give 3GBP. In this way you have the drug companies themselves indirectly financing the system, and if the government overdoes it in his bargaining with doctors, the doctors may simply opt out of the system as it would not be worth their while. Since justice has been described by Heraclitus as conflict, and since the principle of justice is always considered among the principles of biomedical ethics, it seems that this system is fair and just for all. The GP is given a fund to manage to the best of his ability within the constraints that exist and therefore the measure he uses with people will almost always be equal and fair.

Not to say that the British system does not have its faults. But in keeping with the subject of drugs, we have the same problem when it comes to prescribing drugs here. In private practice you tend to prescribe by making a cost-benefit analysis and of course by assessing the needs and the expense to the patient. Some patients can afford more than others and therefore can be offered the brand drug. As long as there is no conflict of interest, it is all fine. But if you had to ask me to decide between a brand drug and a cheaper one, I would take the safe road for my patients, especially if I have to answer for any harm which the drug causes. Asking me to mind the coffers compromises my duty to my patients. If, on the other hand, all doctors are given funds to manage, they will find the best way to manage those funds to the best of their abilities so that they will not be caught in a position of not having money for drugs for their patients. Of course one cannot expect doctors to participate in such management programmes without remuneration.

The government seems to be keen on providing a system whereby patients are registered with a GP. This can be very useful and just towards patients indirectly – as it saves the government money. In Italy, the government makes most of the calls because it is the government that pays for the medication and the doctors’ bills. But in reality it seems that doctors are very unhappy. Moreover they have to deal with policing. The first proposals for a reform in primary care in Malta failed because the government failed to notice he extra burden which was going to be put on GPs without thinking of their remuneration. Indeed why should I take on extra medico-legal responsibility without being paid for it? Even if I am made to input information in a general computerised system, it is going to cost me time, and indeed more waiting time for patients. We can learn from both the Italian and the British systems. Other countries can show what should be done and what should not have been done. In the first instance one should never police a profession, other than perhaps, as was the case, by having civilian TCU inspectors. Secondly, if the government is to save and manage its money more effectively, giving the reins to GPs can only be effective if it is a win-win situation. Unfortunately there are some who by win-win think that threats, such as having nurse practitioners take away one’s daily bread, is a legitimate way – one wins only because one fears a loss.

Whilst out British colleagues have it going only too well for them, and perhaps the patients are not that better off because they have to wait two weeks sometimes in order to see their GP, the only way we would not rock the system is to introduce something which would benefit government, doctors, and above all patients. In reality it is not all that complicated.

The coupon system is simple and effective. One gives coupons to people and they pay the GP with them. The GP then exchanges these with the government. There can be a specific (worked on average) number of coupons per person, varying with conditions, afflictions and age. Coupons can even be transferable in order to avoid extra costs. One can still register with a GP without introducing the inconvenience of having two systems and without making people pay for a simple ticket of referral. But to say that you need a ticket of referral from your private GP whilst telling people that they still can go to a health centre is confusing to say the least. More morally problematic would be to allow a choice of registration with either private doctors or health centre; it would burden health centres whilst preying on fear of patients.

Unless one contemplates a multiple registration system – to be registered in one area and with a group of doctors, the system is bound to raise eyebrows. Two years before election time this would be political suicide. Let’s remember the VAT experience – morally sound in its principles but bulldozed in at a very dear cost.

Pierre Mallia is Associate Professor in Family Medicine, Patients’ Rights and Bioethics at the University of Malta; he is also Ethics Advisor to the Medical Council of Malta. He is also former president of the Malta College of Family Doctors.

  • don't miss